A plant biotechnology approach that uses herbicide-resistance co-editing markers (ALS or EPSP) combined with a counter-selectable marker to efficiently isolate rare chromosomal inversion events without T-DNA integration. Enables identification of non-transgenic edited plants across multiple species.
This solution addresses a key bottleneck in plant genome engineering: the isolation of rare chromosomal inversion events induced by RNA-guided nucleases. Because such inversions occur at very low frequency, researchers traditionally need to screen large populations of edited individuals to find the desired event. This approach uses a co-editing strategy that leverages herbicide-resistance variants of the ALS or EPSP genes as dominant markers to identify edited plants, without requiring T-DNA integration. A conditionally toxic counter-selection gene eliminates T-DNA-containing events, leaving only clean, non-transgenic inversion events for screening.
The individual components have been validated in prior work: herbicide-resistance ALS and EPSP variants have been successfully used as co-editing markers in multiple plant species, and the conditionally toxic counter-selection gene has demonstrated near-complete elimination of T-DNA-containing events across four species. The full co-editing-to-inversion pipeline has not yet been executed end-to-end. Near-term validation steps include analyzing ALS and EPSP genes in target species to design editing approaches, assembling and testing T-DNA vectors in transient assays with amplicon sequencing confirmation, identifying efficient guide RNAs for inversion breakpoints, engineering orthogonal CRISPR T-DNA constructs, and producing editing events through Agrobacterium-mediated transformation followed by regeneration, counter-selection, and PCR-based inversion screening on DNA pools.
CEA is a French public research organization with multi‑site campuses and large‑scale scientific infrastructure, operating across the research‑to‑industry continuum with a strong applied focus. Industry engages through co‑located technology institutes, joint laboratories, contract R&D, and access to pilot lines and test facilities on campuses embedded in the Paris‑Saclay and Grenoble innovation clusters. This model supports rapid prototyping, scale‑up, and validation under industrially relevant conditions. Research is funded by the French government alongside competitive awards from national programs and the European Commission. A tech transfer office manages IP, licensing, and venture creation with startup support on major sites.